Home LiteratureArticle Details
PMID: 19867604 Published · ppublish English Journal Article

THE PRESENCE OF PROTECTIVE SUBSTANCES IN HUMAN SERUM DURING LOBAR PNEUMONIA.

The Journal of experimental medicine ·Vol. 16 ·No. 5 ·1912-11-01 ·Pages 665-79

Dochez AR

Abstract

These experiments demonstrate that protective substances are usually present in the blood of patients recovering from lobar pneumonia. As a rule, the appearance of protective bodies in the blood, when demonstrable, coincides rather sharply with the period of critical fall in temperature and the disappearance of symptoms. These substances are not present in the blood in any measurable degree before the crisis, but afterward they may reach a considerable concentration. In certain instances, protective substances either become evident some time after the occurrence of the crisis, or cannot be demonstrated at any period of the disease. Experiments in which it is possible to test serum against an homologous strain of pneumococcus yield in the majority of cases evidence of the presence of protective bodies; whereas in those in which stock cultures are used, the serum, as a rule, shows no protection. The development of specific protective substances in the serum of patients with lobar pneumonia suggests that these bodies may play a part in the mechanism of recovery.

Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Dochez A R
Hospital of The Rockefeller Institute for Medical Research, New York.
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1912-11-01
Pages
665-79
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2124994
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]